Business (Tables) |
6 Months Ended | |||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2023 | ||||||||||||||||||||||||||||||||||
Schedule Of Entities In Control [Abstract] | ||||||||||||||||||||||||||||||||||
Summary of entities in control | The consolidated financial statements of Benitec Biopharma Inc. are presented in United States dollars and consist of Benitec Biopharma Inc. and its wholly owned subsidiaries as listed below. Aside from Benitec Biopharma Proprietary Limited, the international subsidiaries are dormant.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Schedule of entities in control. No definition available.
|